On the testosterone side, the side effect profile is whatever your existing TRT protocol already carries: this stack doesn't change your hormone dosing, so it doesn't add new hormone-related risk on top of what your clinician is already monitoring
As we age, GHRH signaling weakens
In the body, arginine is the largest source of nitrogen used for production of nitric oxide, which relaxes blood vessels, improving blood flow throughout the body
Interestingly, it has been reported that SFN inhibited the activation of NLRP1, NLRP3, and NLRC4 inflammasomes [66,67]
Early and late assessments is a clear strength of this study
Methylation levels of NLRP3, TGF1, MCP-1, and TNFSF2 are significantly lower in DR patients compared to healthy individuals, suggesting that hypomethylation of these genes contributes to DR progression [66]